Tg Therapeutics Inc (TGTX)

EBITDA

$21.77M

Quarterly · Period ending: · USD

TGTX logo

TGTX EBITDA

Latest reported$21.77M
TGTX Quarterly EBITDA ($100.00K → $21.77M)
High-resolution chart · PNG

TGTX ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-1,456,368
-197,446
2,341,752
-944,651
-3,080,823
-1,402,675
-600,000
-500,000
-700,000
-1,000,000
-800,000
-1,200,000
800,000
-1,300,000
-1,600,000
-1,000,000
-1,700,000
-800,000
-1,200,000
-1,100,000
-600,000
100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.